Rhythm Pharma (RYTM.US) — market event timeline

nashnova tracks 1 market event mentioning Rhythm Pharma (RYTM.US) as of 2026-11-04, each with a dated one-line analysis of how the event relates to the asset.

1. 2026-11-04AstraZeneca Offers Approximately $10 Billion to Acquire Rare Disease Drugmaker Rhythm

   Direct acquisition target. AstraZeneca offers $124 per share, a ~30% premium to the current price, with the stock expected to converge toward the offer price.

For research and information only — not investment advice.